Cailin Morrison

Cailin has taught undergraduate and postgraduate courses at universities in the United Kingdom, Canada, Sri Lanka and Hong Kong. She has designed and delivered courses in business law, international trade law, global health, development law, food security, intellectual property law with a focus on pharmaceutical patents, and healthcare law. In addition to serving in various academic roles, Cailin is a visiting guest lecturer on the MSc in Public Health at the Brighton sussex Medical School and the MSc in Food Sciences in the Department of Clinical Sciences and Nutrition at the University of Chester. She has held two visiting research fellowships at the Lauterpacht Centre for International Law at the University of Cambridge and was a Visiting Researcher at the Centre for Intellectual Property and Information Law (CIPIL), Faculty of Law, University of Cambridge, UK.

Cailin is a senior lecturer in law and from 2022 until 2025, she was the Academic Subject Lead in Law in the School of Business & Law at the University of Brighton. She is a module leader on the LLM in Law and Social Justice and is a module leader and lecturer on the LLB programmes.

Cailin is an external consultant on the Health and Development Roster for UNDP. She is an expert in international trade law,  AI governance, WTO law, intellectual property rights law, pharmaceutical patents, healthcare law, and global health policy. Cailin has provided technical support and analysis to UNDP, UNITAID and UNAIDS to identify and assist LMICs in reviewing, developing and implementing WTO TRIPS compliant laws to further advance public health equity and effectiveness. In addition, she has provided written commentary to the WTO, WIPO, and, WHO on health-related trade issues. She has engaged with government officials, pharmaceutical industry leaders and local NGOs throughout Africa, Central America, South America, Europe, South-East Asia, and North America on equitable access to medical products, and compliance with international trade agreements.

Her current research is situated at the intersection of IP, AI governance and healthcare regulation. She is currently leading two projects: one on the development of an ethical framework for regulating generative AI systems in clinical settings, and another examining legal liabilities associated with AI augmented medical diagnostic tools. These projects reflect her broader scholarly commitment to advancing normative and regulatory frameworks that support equitable and responsible innovation in health technologies.

Cailin would be delighted to supervise students in the areas of her research interests, namely Artificial Intelligence and Regulation, International Trade Law, Law and Development, Intellectual Property Rights Law, and Global Health Policy.